Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
Salvatore AlfieriRebecca RomanòSara MarcegliaVincenzo De GiorgiKetty PerisPietro SollenaAlfredo PiccerilloRuggero MoroGiulio GualdiPaolo Antonio AsciertoMarco PallaMiriam PaoneLaura EibenschutzFrancesco SpagnoloPaola QueiroloDaria Maria FilippiniStefano CavalieriCarlo ResteghiniCristiana BergaminiAntonello ManocchioLisa LicitraPaolo BossiPublished in: The oncologist (2024)
Our retrospective results suggest that HHIs should be continued after cCR to improve DFS in BCC.